Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
Venglustat malate by Sanofi for Gaucher Disease Type III: Likelihood of Approval
Venglustat malate is under clinical development by Sanofi and currently in Phase III for Gaucher Disease Type III. According to...
Risk adjusted net present value: What is the current valuation of Sanofi's Venglustat malate?
Venglustat malate is a small molecule commercialized by Sanofi, with a leading Phase III program in Tay-Sachs Disease. According to...
Venglustat malate by Sanofi for Gaucher Disease Type III: Likelihood of Approval
Venglustat malate is under clinical development by Sanofi and currently in Phase III for Gaucher Disease Type III. According to...
Risk adjusted net present value: What is the current valuation of Sanofi's Venglustat malate?
Venglustat malate is a small molecule commercialized by Sanofi, with a leading Phase III program in Fabry Disease. According to...